Antibody tests for identification of current and past infection with SARS‐CoV‐2

T Fox, J Geppert, J Dinnes, K Scandrett… - Cochrane database …, 2022 - cochranelibrary.com
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

Diagnosis for COVID-19: current status and future prospects

MDA Kabir, R Ahmed, SMA Iqbal… - Expert Review of …, 2021 - Taylor & Francis
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19), a respiratory illness
caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its …

Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers

N Lagerqvist, KT Maleki, J Verner-Carlsson… - Scientific reports, 2021 - nature.com
We evaluated the performance of 11 SARS-CoV-2 antibody tests using a reference set of
heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some of …

Plant molecular farming as a strategy against COVID-19–the Italian perspective

C Lico, L Santi, S Baschieri, E Noris… - Frontiers in plant …, 2020 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed more than
37,000 people in Italy and has caused widespread socioeconomic disruption. Urgent …

[HTML][HTML] Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension …

H Zhao, M Wang, P Muthelo, L Löf, F Sterky, R Gallini… - New biotechnology, 2022 - Elsevier
A homogeneous PCR-based assay for sensitive and specific detection of antibodies in
serum or dried blood spots (DBS) is presented and the method is used to monitor individuals …

Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021

J Beser, I Galanis, T Enkirch, S Kühlmann Berenzon… - Scientific Reports, 2022 - nature.com
A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April–
May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel …

[HTML][HTML] Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

FJ Zapatero-Belinchón, R Moeller, L Lasswitz… - Iscience, 2021 - cell.com
Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …

Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants

F Fagiani, R Frigerio, AM Salzano, A Scaloni… - Biotechnology …, 2024 - Springer
Objectives The aim of this work was to rapidly produce in plats two recombinant antigens
(RBDw-Fc and RBDo-Fc) containing the receptor binding domain (RBD) of the spike (S) …

[PDF][PDF] Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

J Francisco, R Moeller, L Lasswitz, AK Overby… - researchgate.net
Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …

[HTML][HTML] Evaluation of Eleven SARS-CoV-2 Antibody Tests by using Samples from Patients with Defined IgG Antibody Titers

N Lagerqvist, K Maleki, J Verner-Carlsson, M Olausson… - 2021 - europepmc.org
We evaluated the performance of eleven SARS-CoV-2 antibody tests using a reference set
of heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some …